Lodder-van der Vlies Dalith, Droogh-de Greve Kitty E, de Win Jos L M, van der Zaag-Loonen Hester J, van Bruggen J A Rykel, Markestein Hetty P, Gratama Jan Willem C
Gelre Ziekenhuizen, Apeldoorn.
Ned Tijdschr Geneeskd. 2015;159:A8636.
To analyse the percentage of women with a family history of breast cancer referred by general practitioners (GPs) for a screening mammography in accordance with the Dutch Breast Cancer Guideline produced by the Netherlands Comprehensive Cancer Centre (IKNL).
Prospective cohort study.
Women referred by their GP between December 2011 and December 2012 for mammography, with the indication "family history of breast cancer", were invited to take part in this study. A trained radiology laboratory assistant carried out a structured questionnaire to assess their risk on the basis of the categories of the 2008 IKNL guideline "Family history of breast/ovarian cancer". Based on the presence of certain risk factors, the women were allocated to one of the following groups: "referral for mammography", "referral to a clinical geneticist" or "no referral indicated".
242 women were referred by their GPs to the Radiology Department for mammography on the basis of family history; we included 210 women in our study. Their ages ranged from 25 to 77 years (mean age: 48 years). Forty-five patients (21%) were referred for mammography in accordance with the guideline. Twenty-two patients (10%) should have been referred to a clinical geneticist according to the guideline, whereas 143 patients (68%) did not meet the criteria for a screening mammography outside the screening programme.
In only 21% of patients referred by their GPs for a screening mammography, with "family history" given as the reason, this referral was in accordance with the standard of the Dutch College of General Practitioners (NHG) or the IKNL guideline. Screening outside the breast cancer screening programme was not indicated according to the guideline for the majority of the women. Referral of 10% of the women referred should have been to a clinical geneticist; this figure rises to as many as 20% using the 2012 IKNL guideline.
根据荷兰综合癌症中心(IKNL)制定的荷兰乳腺癌指南,分析由全科医生(GP)转诊进行乳腺钼靶筛查的有乳腺癌家族史女性的比例。
前瞻性队列研究。
邀请在2011年12月至2012年12月期间被全科医生转诊进行乳腺钼靶检查且指征为“乳腺癌家族史”的女性参与本研究。一名经过培训的放射学实验室助理根据2008年IKNL指南“乳腺癌/卵巢癌家族史”的类别进行结构化问卷调查,以评估她们的风险。根据某些风险因素的存在情况,将这些女性分为以下几组之一:“转诊进行乳腺钼靶检查”、“转诊给临床遗传学家”或“无需转诊”。
242名女性因家族史被全科医生转诊至放射科进行乳腺钼靶检查;我们的研究纳入了210名女性。她们的年龄在25岁至77岁之间(平均年龄:48岁)。45名患者(21%)根据指南被转诊进行乳腺钼靶检查。根据指南,22名患者(10%)应被转诊给临床遗传学家,而143名患者(68%)不符合筛查计划外乳腺钼靶筛查的标准。
在因“家族史”被全科医生转诊进行乳腺钼靶筛查的患者中,只有21%的转诊符合荷兰全科医生学院(NHG)或IKNL指南的标准。根据指南,大多数女性无需在乳腺癌筛查计划外进行筛查。10%被转诊的女性应被转诊给临床遗传学家;按照2012年IKNL指南,这一比例高达20%。